Product NDC: | 0409-0302 |
Proprietary Name: | Topotecan |
Non Proprietary Name: | TOPOTECAN HYDROCHLORIDE |
Active Ingredient(s): | 1 mg/mL & nbsp; TOPOTECAN HYDROCHLORIDE |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION, CONCENTRATE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0409-0302 |
Labeler Name: | Hospira, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA200582 |
Marketing Category: | NDA |
Start Marketing Date: | 20110202 |
Package NDC: | 0409-0302-01 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0409-0302-01) > 4 mL in 1 VIAL, SINGLE-USE |
NDC Code | 0409-0302-01 |
Proprietary Name | Topotecan |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0409-0302-01) > 4 mL in 1 VIAL, SINGLE-USE |
Product NDC | 0409-0302 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | TOPOTECAN HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION, CONCENTRATE |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110202 |
Marketing Category Name | NDA |
Labeler Name | Hospira, Inc. |
Substance Name | TOPOTECAN HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] |